PURINETHOL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Stason Pharmaceuticals, Inc.. The primary component is Mercaptopurine.
Product ID | 60763-601_107943c8-e56e-454b-a876-2cf5760c3f73 |
NDC | 60763-601 |
Product Type | Human Prescription Drug |
Proprietary Name | PURINETHOL |
Generic Name | Mercaptopurine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2021-01-15 |
Marketing Category | NDA / NDA |
Application Number | NDA009053 |
Labeler Name | Stason Pharmaceuticals, Inc. |
Substance Name | MERCAPTOPURINE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-01-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
60763-601 | PURINETHOL | Mercaptopurine |
0054-4581 | Mercaptopurine | Mercaptopurine |
0378-3547 | Mercaptopurine | mercaptopurine |
49884-922 | mercaptopurine | mercaptopurine |
69076-913 | Mercaptopurine | Mercaptopurine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PURINETHOL 77140307 3391060 Dead/Cancelled |
STASON PHARMACEUTICALS, INC. 2007-03-26 |
PURINETHOL 71647991 0587330 Live/Registered |
BURROUGHS WELLCOME & CO. (U. S. A.) INC. 1953-06-01 |